nodes	percent_of_prediction	percent_of_DWPC	metapath
Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.503	0.564	CbGaD
Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.389	0.436	CbGaD
Pipotiazine—DRD1—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00586	0.0702	CbGpPWpGaD
Pipotiazine—DRD1—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00569	0.0681	CbGpPWpGaD
Pipotiazine—DRD1—Dopamine receptors—DRD2—Gilles de la Tourette syndrome	0.0053	0.0635	CbGpPWpGaD
Pipotiazine—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00442	0.053	CbGpPWpGaD
Pipotiazine—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00429	0.0515	CbGpPWpGaD
Pipotiazine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00295	0.0354	CbGpPWpGaD
Pipotiazine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00255	0.172	CbGeAlD
Pipotiazine—HTR1A—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00158	0.019	CbGpPWpGaD
Pipotiazine—DRD1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00152	0.0182	CbGpPWpGaD
Pipotiazine—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.00148	0.0177	CbGpPWpGaD
Pipotiazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0014	0.0168	CbGpPWpGaD
Pipotiazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00136	0.0163	CbGpPWpGaD
Pipotiazine—HTR1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00131	0.0156	CbGpPWpGaD
Pipotiazine—DRD1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00129	0.0155	CbGpPWpGaD
Pipotiazine—DRD1—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00129	0.0154	CbGpPWpGaD
Pipotiazine—DRD1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00126	0.0151	CbGpPWpGaD
Pipotiazine—DRD1—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.0012	0.0144	CbGpPWpGaD
Pipotiazine—DRD1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00117	0.014	CbGpPWpGaD
Pipotiazine—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00115	0.0137	CbGpPWpGaD
Pipotiazine—HTR2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00113	0.0135	CbGpPWpGaD
Pipotiazine—HTR1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00111	0.0133	CbGpPWpGaD
Pipotiazine—DRD1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00109	0.013	CbGpPWpGaD
Pipotiazine—HTR1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00108	0.013	CbGpPWpGaD
Pipotiazine—DRD1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00106	0.0127	CbGpPWpGaD
Pipotiazine—SLC22A1—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00103	0.0123	CbGpPWpGaD
Pipotiazine—HTR1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00101	0.0121	CbGpPWpGaD
Pipotiazine—DRD1—midbrain—Gilles de la Tourette syndrome	0.00101	0.068	CbGeAlD
Pipotiazine—DRD1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000984	0.0118	CbGpPWpGaD
Pipotiazine—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000977	0.0117	CbGpPWpGaD
Pipotiazine—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.000972	0.0117	CbGpPWpGaD
Pipotiazine—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000962	0.0115	CbGpPWpGaD
Pipotiazine—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000949	0.0114	CbGpPWpGaD
Pipotiazine—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000936	0.0112	CbGpPWpGaD
Pipotiazine—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000934	0.0112	CbGpPWpGaD
Pipotiazine—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000908	0.0109	CbGpPWpGaD
Pipotiazine—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00087	0.0104	CbGpPWpGaD
Pipotiazine—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000846	0.0101	CbGpPWpGaD
Pipotiazine—DRD1—nervous system—Gilles de la Tourette syndrome	0.000827	0.0559	CbGeAlD
Pipotiazine—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000822	0.00985	CbGpPWpGaD
Pipotiazine—DRD1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00082	0.00983	CbGpPWpGaD
Pipotiazine—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000808	0.00969	CbGpPWpGaD
Pipotiazine—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000798	0.00956	CbGpPWpGaD
Pipotiazine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000796	0.0538	CbGeAlD
Pipotiazine—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000785	0.0094	CbGpPWpGaD
Pipotiazine—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000731	0.00876	CbGpPWpGaD
Pipotiazine—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000705	0.00845	CbGpPWpGaD
Pipotiazine—DRD1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000689	0.00826	CbGpPWpGaD
Pipotiazine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000658	0.0445	CbGeAlD
Pipotiazine—SLC22A1—nervous system—Gilles de la Tourette syndrome	0.000655	0.0443	CbGeAlD
Pipotiazine—DRD1—brain—Gilles de la Tourette syndrome	0.000632	0.0427	CbGeAlD
Pipotiazine—SLC22A1—central nervous system—Gilles de la Tourette syndrome	0.00063	0.0426	CbGeAlD
Pipotiazine—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000619	0.00742	CbGpPWpGaD
Pipotiazine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000594	0.0402	CbGeAlD
Pipotiazine—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000593	0.0071	CbGpPWpGaD
Pipotiazine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000541	0.0366	CbGeAlD
Pipotiazine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000521	0.0352	CbGeAlD
Pipotiazine—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00052	0.00624	CbGpPWpGaD
Pipotiazine—SLC22A1—brain—Gilles de la Tourette syndrome	0.000501	0.0338	CbGeAlD
Pipotiazine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000489	0.033	CbGeAlD
Pipotiazine—ALB—brain—Gilles de la Tourette syndrome	0.000479	0.0324	CbGeAlD
Pipotiazine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000471	0.0318	CbGeAlD
Pipotiazine—Domperidone—DRD3—Gilles de la Tourette syndrome	0.000438	0.0445	CrCbGaD
Pipotiazine—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000427	0.00512	CbGpPWpGaD
Pipotiazine—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000415	0.00497	CbGpPWpGaD
Pipotiazine—HTR1A—brain—Gilles de la Tourette syndrome	0.000413	0.0279	CbGeAlD
Pipotiazine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.000401	0.0048	CbGpPWpGaD
Pipotiazine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.0004	0.0407	CrCbGaD
Pipotiazine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000392	0.0265	CbGeAlD
Pipotiazine—DRD2—brain—Gilles de la Tourette syndrome	0.000374	0.0252	CbGeAlD
Pipotiazine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000322	0.0218	CbGeAlD
Pipotiazine—Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.000311	0.0316	CrCbGaD
Pipotiazine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.00031	0.021	CbGeAlD
Pipotiazine—DRD1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000305	0.00366	CbGpPWpGaD
Pipotiazine—Propiomazine—DRD4—Gilles de la Tourette syndrome	0.000304	0.0309	CrCbGaD
Pipotiazine—Domperidone—DRD2—Gilles de la Tourette syndrome	0.000303	0.0308	CrCbGaD
Pipotiazine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000301	0.0306	CrCbGaD
Pipotiazine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000298	0.0202	CbGeAlD
Pipotiazine—DRD1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000296	0.00355	CbGpPWpGaD
Pipotiazine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000294	0.0198	CbGeAlD
Pipotiazine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000287	0.0194	CbGeAlD
Pipotiazine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000283	0.0191	CbGeAlD
Pipotiazine—DRD1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000276	0.00331	CbGpPWpGaD
Pipotiazine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.000273	0.0278	CrCbGaD
Pipotiazine—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.000273	0.0277	CrCbGaD
Pipotiazine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.00026	0.0264	CrCbGaD
Pipotiazine—Zuclopenthixol—DRD2—Gilles de la Tourette syndrome	0.000253	0.0257	CrCbGaD
Pipotiazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00025	0.00299	CbGpPWpGaD
Pipotiazine—HTR2A—brain—Gilles de la Tourette syndrome	0.000246	0.0167	CbGeAlD
Pipotiazine—Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.000245	0.0249	CrCbGaD
Pipotiazine—Quetiapine—DRD4—Gilles de la Tourette syndrome	0.000245	0.0249	CrCbGaD
Pipotiazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000243	0.00291	CbGpPWpGaD
Pipotiazine—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000231	0.00277	CbGpPWpGaD
Pipotiazine—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00023	0.00276	CbGpPWpGaD
Pipotiazine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.000227	0.0231	CrCbGaD
Pipotiazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000226	0.00271	CbGpPWpGaD
Pipotiazine—Promazine—DRD4—Gilles de la Tourette syndrome	0.000225	0.0229	CrCbGaD
Pipotiazine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000225	0.00269	CbGpPWpGaD
Pipotiazine—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000225	0.00269	CbGpPWpGaD
Pipotiazine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000224	0.0152	CbGeAlD
Pipotiazine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.000224	0.0228	CrCbGaD
Pipotiazine—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000224	0.00268	CbGpPWpGaD
Pipotiazine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000222	0.0226	CrCbGaD
Pipotiazine—Thiothixene—DRD2—Gilles de la Tourette syndrome	0.000218	0.0222	CrCbGaD
Pipotiazine—Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.000215	0.0219	CrCbGaD
Pipotiazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000215	0.00257	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000214	0.00256	CbGpPWpGaD
Pipotiazine—Quetiapine—DRD3—Gilles de la Tourette syndrome	0.000211	0.0215	CrCbGaD
Pipotiazine—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000209	0.00251	CbGpPWpGaD
Pipotiazine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000209	0.0212	CrCbGaD
Pipotiazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000209	0.0025	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000208	0.00249	CbGpPWpGaD
Pipotiazine—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000203	0.00244	CbGpPWpGaD
Pipotiazine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000203	0.00244	CbGpPWpGaD
Pipotiazine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.000198	0.0202	CrCbGaD
Pipotiazine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000197	0.00236	CbGpPWpGaD
Pipotiazine—Zuclopenthixol—HTR2A—Gilles de la Tourette syndrome	0.000196	0.0199	CrCbGaD
Pipotiazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000194	0.00233	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000194	0.00232	CbGpPWpGaD
Pipotiazine—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.000189	0.0192	CrCbGaD
Pipotiazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000189	0.00226	CbGpPWpGaD
Pipotiazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000186	0.00222	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000184	0.00221	CbGpPWpGaD
Pipotiazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000183	0.00219	CbGpPWpGaD
Pipotiazine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000182	0.00218	CbGpPWpGaD
Pipotiazine—Propiomazine—DRD2—Gilles de la Tourette syndrome	0.000181	0.0184	CrCbGaD
Pipotiazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00018	0.00216	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000179	0.00214	CbGpPWpGaD
Pipotiazine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.000175	0.0178	CrCbGaD
Pipotiazine—SLC22A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000172	0.00206	CbGpPWpGaD
Pipotiazine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.000171	0.0174	CrCbGaD
Pipotiazine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.000171	0.0174	CrCbGaD
Pipotiazine—Thiothixene—HTR2A—Gilles de la Tourette syndrome	0.000169	0.0171	CrCbGaD
Pipotiazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000168	0.00201	CbGpPWpGaD
Pipotiazine—Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.000166	0.0169	CrCbGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000166	0.00199	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000163	0.00195	CbGpPWpGaD
Pipotiazine—Thioridazine—DRD2—Gilles de la Tourette syndrome	0.000163	0.0165	CrCbGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000162	0.00194	CbGpPWpGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000159	0.00191	CbGpPWpGaD
Pipotiazine—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.000158	0.0161	CrCbGaD
Pipotiazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000158	0.0019	CbGpPWpGaD
Pipotiazine—DRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000158	0.0019	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000157	0.00188	CbGpPWpGaD
Pipotiazine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.000155	0.0158	CrCbGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000154	0.00185	CbGpPWpGaD
Pipotiazine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.000153	0.0155	CrCbGaD
Pipotiazine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.000151	0.0153	CrCbGaD
Pipotiazine—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.000149	0.0152	CrCbGaD
Pipotiazine—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000147	0.00177	CbGpPWpGaD
Pipotiazine—Quetiapine—DRD2—Gilles de la Tourette syndrome	0.000146	0.0149	CrCbGaD
Pipotiazine—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	0.000146	0.0148	CrCbGaD
Pipotiazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000144	0.00172	CbGpPWpGaD
Pipotiazine—Propiomazine—HTR2A—Gilles de la Tourette syndrome	0.00014	0.0143	CrCbGaD
Pipotiazine—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00014	0.00168	CbGpPWpGaD
Pipotiazine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000136	0.00163	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000136	0.00163	CbGpPWpGaD
Pipotiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000136	0.00162	CbGpPWpGaD
Pipotiazine—Promazine—DRD2—Gilles de la Tourette syndrome	0.000134	0.0137	CrCbGaD
Pipotiazine—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.000133	0.0136	CrCbGaD
Pipotiazine—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000127	0.00152	CbGpPWpGaD
Pipotiazine—Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.000126	0.0128	CrCbGaD
Pipotiazine—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000125	0.00149	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000123	0.00147	CbGpPWpGaD
Pipotiazine—ALB—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000122	0.00146	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000121	0.00145	CbGpPWpGaD
Pipotiazine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.00012	0.0122	CrCbGaD
Pipotiazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000119	0.00143	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000119	0.00143	CbGpPWpGaD
Pipotiazine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	0.000118	0.012	CrCbGaD
Pipotiazine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.000118	0.012	CrCbGaD
Pipotiazine—Imipramine—DRD2—Gilles de la Tourette syndrome	0.000118	0.012	CrCbGaD
Pipotiazine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000118	0.00141	CbGpPWpGaD
Pipotiazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000117	0.0014	CbGpPWpGaD
Pipotiazine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	0.000117	0.0118	CrCbGaD
Pipotiazine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	0.000115	0.0117	CrCbGaD
Pipotiazine—Quetiapine—HTR2A—Gilles de la Tourette syndrome	0.000113	0.0115	CrCbGaD
Pipotiazine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000109	0.00131	CbGpPWpGaD
Pipotiazine—Promazine—HTR2A—Gilles de la Tourette syndrome	0.000104	0.0106	CrCbGaD
Pipotiazine—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000103	0.00124	CbGpPWpGaD
Pipotiazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000102	0.00123	CbGpPWpGaD
Pipotiazine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	9.26e-05	0.00111	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.21e-05	0.0011	CbGpPWpGaD
Pipotiazine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	9.14e-05	0.0093	CrCbGaD
Pipotiazine—Imipramine—HTR2A—Gilles de la Tourette syndrome	9.1e-05	0.00925	CrCbGaD
Pipotiazine—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.94e-05	0.00107	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.88e-05	0.00106	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.36e-05	0.001	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—HDC—Gilles de la Tourette syndrome	8.34e-05	0.000999	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.33e-05	0.000998	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.12e-05	0.000973	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.92e-05	0.000949	CbGpPWpGaD
Pipotiazine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.79e-05	0.000934	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.69e-05	0.000921	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.56e-05	0.000906	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	7.48e-05	0.000897	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.19e-05	0.000862	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.16e-05	0.000858	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.98e-05	0.000837	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.95e-05	0.000833	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	6.88e-05	0.000825	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.84e-05	0.00082	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.75e-05	0.000809	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.64e-05	0.000796	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.5e-05	0.00078	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.31e-05	0.000757	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.21e-05	0.000745	CbGpPWpGaD
Pipotiazine—ALB—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	6.19e-05	0.000742	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.19e-05	0.000742	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.13e-05	0.000735	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.03e-05	0.000723	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.83e-05	0.000699	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	5.83e-05	0.000699	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.62e-05	0.000673	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.3e-05	0.000635	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.02e-05	0.000601	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.94e-05	0.000592	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.8e-05	0.000575	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.56e-05	0.000546	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	4.5e-05	0.000539	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.47e-05	0.000536	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.4e-05	0.000528	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.25e-05	0.000509	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.12e-05	0.000494	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4e-05	0.000479	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.84e-05	0.00046	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.73e-05	0.000447	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.67e-05	0.00044	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.62e-05	0.000434	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.56e-05	0.000427	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.32e-05	0.000398	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.13e-05	0.000375	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.69e-05	0.000323	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.36e-05	0.000283	CbGpPWpGaD
